Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 333 (6046): 1157-1160

Copyright © 2011 by the American Association for the Advancement of Science

The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

Nicolas Stransky,1,* Ann Marie Egloff,2,* Aaron D. Tward,1,3,4,* Aleksandar D. Kostic,1,5 Kristian Cibulskis,1 Andrey Sivachenko,1 Gregory V. Kryukov,1,5 Michael S. Lawrence,1 Carrie Sougnez,1 Aaron McKenna,1 Erica Shefler,1 Alex H. Ramos,1 Petar Stojanov,1 Scott L. Carter,1 Douglas Voet,1 Maria L. Cortés,1 Daniel Auclair,1 Michael F. Berger,1 Gordon Saksena,1 Candace Guiducci,1 Robert C. Onofrio,1 Melissa Parkin,1 Marjorie Romkes,6 Joel L. Weissfeld,7 Raja R. Seethala,8 Lin Wang,8 Claudia Rangel-Escareño,9 Juan Carlos Fernandez-Lopez,9 Alfredo Hidalgo-Miranda,9 Jorge Melendez-Zajgla,9 Wendy Winckler,1 Kristin Ardlie,1 Stacey B. Gabriel,1 Matthew Meyerson,1,5,10,11 Eric S. Lander,1,5,12 Gad Getz,1 Todd R. Golub,1,5,11,13,14,{dagger} Levi A. Garraway,1,5,10,11,{dagger},{ddagger} Jennifer R. Grandis2,15,{dagger},{ddagger}

Abstract: Head and neck squamous cell carcinoma (HNSCC) is a common, morbid, and frequently lethal malignancy. To uncover its mutational spectrum, we analyzed whole-exome sequencing data from 74 tumor-normal pairs. The majority exhibited a mutational profile consistent with tobacco exposure; human papillomavirus was detectable by sequencing DNA from infected tumors. In addition to identifying previously known HNSCC genes (TP53, CDKN2A, PTEN, PIK3CA, and HRAS), our analysis revealed many genes not previously implicated in this malignancy. At least 30% of cases harbored mutations in genes that regulate squamous differentiation (for example, NOTCH1, IRF6, and TP63), implicating its dysregulation as a major driver of HNSCC carcinogenesis. More generally, the results indicate the ability of large-scale sequencing to reveal fundamental tumorigenic mechanisms.

1 The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
2 Department of Otolaryngology, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.
3 Department of Otology and Laryngology, Harvard Medical School, Boston, MA 02114, USA.
4 Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
5 Harvard Medical School, Boston, MA 02115, USA.
6 Department of Medicine, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15261, USA.
7 Department of Epidemiology, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.
8 Department of Pathology, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.
9 Instituto Nacional de Medicina Genómica, Mexico City, 01900, Mexico.
10 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
11 Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
12 Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
13 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
14 Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
15 Department of Pharmacology and Chemical Biology, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.

* These authors contributed equally to this work.

{dagger} These authors contributed equally to this work.

{ddagger} To whom correspondence should be addressed. E-mail: levi_garraway{at}dfci.harvard.edu (L.A.G.); grandisjr{at}upmc.edu (J.R.G.)


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Harnessing Massively Parallel Sequencing in Personalized Head and Neck Oncology.
M. Jessri and C. S. Farah (2014)
Journal of Dental Research 93, 437-444
   Abstract »    Full Text »    PDF »
Notch signaling: switching an oncogene to a tumor suppressor.
C. Lobry, P. Oh, M. R. Mansour, A. T. Look, and I. Aifantis (2014)
Blood 123, 2451-2459
   Abstract »    Full Text »    PDF »
Bioluminescent Imaging of HPV-Positive Oral Tumor Growth and Its Response to Image-Guided Radiotherapy.
R. Zhong, M. Pytynia, C. Pelizzari, and M. Spiotto (2014)
Cancer Res. 74, 2073-2081
   Abstract »    Full Text »    PDF »
Small GTPase RhoE/Rnd3 Is a Critical Regulator of Notch1 Signaling.
Z. Zhu, K. Todorova, K. K. Lee, J. Wang, E. Kwon, I. Kehayov, H.-G. Kim, V. Kolev, G. P. Dotto, S. W. Lee, et al. (2014)
Cancer Res. 74, 2082-2093
   Abstract »    Full Text »    PDF »
Genomic Analysis of Head and Neck Squamous Cell Carcinoma Cell Lines and Human Tumors: A Rational Approach to Preclinical Model Selection.
H. Li, J. S. Wawrose, W. E. Gooding, L. A. Garraway, V. W. Y. Lui, N. D. Peyser, and J. R. Grandis (2014)
Mol. Cancer Res. 12, 571-582
   Abstract »    Full Text »    PDF »
Phase I Study of Oral Rigosertib (ON 01910.Na), a Dual Inhibitor of the PI3K and Plk1 Pathways, in Adult Patients with Advanced Solid Malignancies.
D. W. Bowles, J. R. Diamond, E. T. Lam, C. D. Weekes, D. P. Astling, R. T. Anderson, S. Leong, L. Gore, M. Varella-Garcia, B. W. Vogler, et al. (2014)
Clin. Cancer Res. 20, 1656-1665
   Abstract »    Full Text »    PDF »
Molecular Pathways: HER3 Targeted Therapy.
K. Gala and S. Chandarlapaty (2014)
Clin. Cancer Res. 20, 1410-1416
   Abstract »    Full Text »    PDF »
NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes.
O. An, V. Pendino, M. D'Antonio, E. Ratti, M. Gentilini, and F. D. Ciccarelli (2014)
Database 2014, bau015
   Abstract »    Full Text »    PDF »
Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
J. Zhang, J. Liu, J. Sun, C. Chen, G. Foltz, and B. Lin (2014)
Brief Bioinform 15, 244-255
   Abstract »    Full Text »    PDF »
Impairing squamous differentiation by Klf4 deletion is sufficient to initiate tongue carcinoma development upon K-Ras activation in mice.
M. Abrigo, R. Alvarez, M. L. Paparella, D. E. Calb, E. Bal de Kier Joffe, J. S. Gutkind, and A. R. Raimondi (2014)
Carcinogenesis 35, 662-669
   Abstract »    Full Text »    PDF »
Chemoprevention of Squamous Cell Carcinoma of the Head and Neck: No Time to Lose Momentum.
L. J. Wirth (2014)
Cancer Prevention Research 7, 279-282
   Abstract »    Full Text »    PDF »
Activation of the NOTCH Pathway in Head and Neck Cancer.
W. Sun, D. A. Gaykalova, M. F. Ochs, E. Mambo, D. Arnaoutakis, Y. Liu, M. Loyo, N. Agrawal, J. Howard, R. Li, et al. (2014)
Cancer Res. 74, 1091-1104
   Abstract »    Full Text »    PDF »
Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.
K. Akagi, J. Li, T. R. Broutian, H. Padilla-Nash, W. Xiao, B. Jiang, J. W. Rocco, T. N. Teknos, B. Kumar, D. Wangsa, et al. (2014)
Genome Res. 24, 185-199
   Abstract »    Full Text »    PDF »
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors.
J. F. Shern, L. Chen, J. Chmielecki, J. S. Wei, R. Patidar, M. Rosenberg, L. Ambrogio, D. Auclair, J. Wang, Y. K. Song, et al. (2014)
Cancer Discovery 4, 216-231
   Abstract »    Full Text »    PDF »
Common and Complex Notch1 Mutations in Chinese Oral Squamous Cell Carcinoma.
X. Song, R. Xia, J. Li, Z. Long, H. Ren, W. Chen, and L. Mao (2014)
Clin. Cancer Res. 20, 701-710
   Abstract »    Full Text »    PDF »
Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites.
M. Idogawa, T. Ohashi, Y. Sasaki, R. Maruyama, L. Kashima, H. Suzuki, and T. Tokino (2014)
Hum. Mol. Genet.
   Abstract »    Full Text »    PDF »
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer.
V. W. Y. Lui, N. D. Peyser, P. K.-S. Ng, J. Hritz, Y. Zeng, Y. Lu, H. Li, L. Wang, B. R. Gilbert, I. J. General, et al. (2014)
PNAS 111, 1114-1119
   Abstract »    Full Text »    PDF »
Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas.
D. Schramek, A. Sendoel, J. P. Segal, S. Beronja, E. Heller, D. Oristian, B. Reva, and E. Fuchs (2014)
Science 343, 309-313
   Abstract »    Full Text »    PDF »
Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients.
Y. Kim, P. S. Hammerman, J. Kim, J.-a. Yoon, Y. Lee, J.-M. Sun, M. D. Wilkerson, C. S. Pedamallu, K. Cibulskis, Y. K. Yoo, et al. (2014)
J. Clin. Oncol. 32, 121-128
   Abstract »    Full Text »    PDF »
CR Cistrome: a ChIP-Seq database for chromatin regulators and histone modification linkages in human and mouse.
Q. Wang, J. Huang, H. Sun, J. Liu, J. Wang, Q. Wang, Q. Qin, S. Mei, C. Zhao, X. Yang, et al. (2014)
Nucleic Acids Res. 42, D450-D458
   Abstract »    Full Text »    PDF »
Fifty Years of Tobacco Carcinogenesis Research: From Mechanisms to Early Detection and Prevention of Lung Cancer.
S. S. Hecht and E. Szabo (2014)
Cancer Prevention Research 7, 1-8
   Abstract »    Full Text »    PDF »
Aberrant epidermal differentiation and disrupted {Delta}Np63/Notch regulatory axis in Ets1 transgenic mice.
S. S. Chin, R.-A. Romano, P. Nagarajan, S. Sinha, and L. A. Garrett-Sinha (2013)
Biology Open 2, 1336-1345
   Abstract »    Full Text »    PDF »
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
J. Liu, S. Pan, M. H. Hsieh, N. Ng, F. Sun, T. Wang, S. Kasibhatla, A. G. Schuller, A. G. Li, D. Cheng, et al. (2013)
PNAS 110, 20224-20229
   Abstract »    Full Text »    PDF »
Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.
F. Ganci, A. Sacconi, N. Bossel Ben-Moshe, V. Manciocco, I. Sperduti, L. Strigari, R. Covello, M. Benevolo, E. Pescarmona, E. Domany, et al. (2013)
Ann. Onc. 24, 3082-3088
   Abstract »    Full Text »    PDF »
Small Molecule-based Chemotherapeutic Approach in p16-positive and -negative HNSCC In Vitro.
C. ADERHOLD, A. FABER, G. M. GROBSCHMIDT, A. CHAKRABORTY, A. BOCKMAYER, C. UMBREIT, R. BIRK, J. STERN-STRAETER, K. HORMANN, and J. D. SCHULTZ (2013)
Anticancer Res 33, 5385-5393
   Abstract »    Full Text »    PDF »
AKR1B10, a Transcriptional Target of p53, Is Downregulated in Colorectal Cancers Associated with Poor Prognosis.
T. Ohashi, M. Idogawa, Y. Sasaki, H. Suzuki, and T. Tokino (2013)
Mol. Cancer Res. 11, 1554-1563
   Abstract »    Full Text »    PDF »
Cutaneous Notch Signaling in Health and Disease.
C. Nowell and F. Radtke (2013)
Cold Spring Harb Perspect Med 3, a017772
   Abstract »    Full Text »    PDF »
The Dual Pathway Inhibitor Rigosertib Is Effective in Direct Patient Tumor Xenografts of Head and Neck Squamous Cell Carcinomas.
R. T. Anderson, S. B. Keysar, D. W. Bowles, M. J. Glogowska, D. P. Astling, J. J. Morton, P. Le, A. Umpierrez, J. Eagles-Soukup, G. N. Gan, et al. (2013)
Mol. Cancer Ther. 12, 1994-2005
   Abstract »    Full Text »    PDF »
EGFR Inhibition Promotes an Aggressive Invasion Pattern Mediated by Mesenchymal-like Tumor Cells within Squamous Cell Carcinomas.
D. Basu, A. F. Bewley, S. M. Sperry, K. T. Montone, P. A. Gimotty, K. Rasanen, N. D. Facompre, G. S. Weinstein, H. Nakagawa, J. A. Diehl, et al. (2013)
Mol. Cancer Ther. 12, 2176-2186
   Abstract »    Full Text »    PDF »
CT Imaging Correlates of Genomic Expression for Oral Cavity Squamous Cell Carcinoma.
C. R. Pickering, K. Shah, S. Ahmed, A. Rao, M. J. Frederick, J. Zhang, A. K. Unruh, J. Wang, L. E. Ginsberg, A. J. Kumar, et al. (2013)
AJNR Am. J. Neuroradiol. 34, 1818-1822
   Abstract »    Full Text »    PDF »
Epigenetic Modulation of Signal Transduction Pathways in HPV-Associated HNSCC.
M. J. Worsham, K. M. Chen, T. Ghanem, J. K. Stephen, and G. Divine (2013)
Otolaryngology -- Head and Neck Surgery 149, 409-416
   Abstract »    Full Text »    PDF »
Systematic Interrogation of 3q26 Identifies TLOC1 and SKIL as Cancer Drivers.
D. Hagerstrand, A. Tong, S. E. Schumacher, N. Ilic, R. R. Shen, H. W. Cheung, F. Vazquez, Y. Shrestha, S. Y. Kim, A. O. Giacomelli, et al. (2013)
Cancer Discovery 3, 1044-1057
   Abstract »    Full Text »    PDF »
Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53.
M. A. Gadhikar, M. R. Sciuto, M. V. O. Alves, C. R. Pickering, A. A. Osman, D. M. Neskey, M. Zhao, A. L. Fitzgerald, J. N. Myers, and M. J. Frederick (2013)
Mol. Cancer Ther. 12, 1860-1873
   Abstract »    Full Text »    PDF »
Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma.
R. G. Liao, J. Jung, J. Tchaicha, M. D. Wilkerson, A. Sivachenko, E. M. Beauchamp, Q. Liu, T. J. Pugh, C. S. Pedamallu, D. N. Hayes, et al. (2013)
Cancer Res. 73, 5195-5205
   Abstract »    Full Text »    PDF »
A miR-34a-SIRT6 axis in the squamous cell differentiation network.
K. Lefort, Y. Brooks, P. Ostano, M. Cario-Andre, V. Calpini, J. Guinea-Viniegra, A. Albinger-Hegyi, W. Hoetzenecker, I. Kolfschoten, E. F. Wagner, et al. (2013)
EMBO J. 32, 2248-2263
   Abstract »    Full Text »    PDF »
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms.
B. Przychodzen, A. Jerez, K. Guinta, M. A. Sekeres, R. Padgett, J. P. Maciejewski, and H. Makishima (2013)
Blood 122, 999-1006
   Abstract »    Full Text »    PDF »
Facilitating the use of large-scale biological data and tools in the era of translational bioinformatics.
I. Kouskoumvekaki, N. Shublaq, and S. Brunak (2013)
Brief Bioinform
   Abstract »    Full Text »    PDF »
Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
T. Rampias, E. Pectasides, M. Prasad, C. Sasaki, P. Gouveris, A. Dimou, P. Kountourakis, C. Perisanidis, B. Burtness, T. Zaramboukas, et al. (2013)
Ann. Onc. 24, 2124-2131
   Abstract »    Full Text »    PDF »
Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer.
R. J. Kimple, M. A. Smith, G. C. Blitzer, A. D. Torres, J. A. Martin, R. Z. Yang, C. R. Peet, L. D. Lorenz, K. P. Nickel, A. J. Klingelhutz, et al. (2013)
Cancer Res. 73, 4791-4800
   Abstract »    Full Text »    PDF »
A Poor Prognosis Subtype of HNSCC Is Consistently Observed across Methylome, Transcriptome, and miRNome Analysis.
A. C. Jung, S. Job, S. Ledrappier, C. Macabre, J. Abecassis, A. de Reynies, and B. Wasylyk (2013)
Clin. Cancer Res. 19, 4174-4184
   Abstract »    Full Text »    PDF »
PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer.
A. Herzog, Y. Bian, R. Vander Broek, B. Hall, J. Coupar, H. Cheng, A. L. Sowers, J. D. Cook, J. B. Mitchell, Z. Chen, et al. (2013)
Clin. Cancer Res. 19, 3808-3819
   Abstract »    Full Text »    PDF »
Exploiting the Head and Neck Cancer Oncogenome: Widespread PI3K-mTOR Pathway Alterations and Novel Molecular Targets.
R. Iglesias-Bartolome, D. Martin, and J. S. Gutkind (2013)
Cancer Discovery 3, 722-725
   Abstract »    Full Text »    PDF »
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers.
V. W. Y. Lui, M. L. Hedberg, H. Li, B. S. Vangara, K. Pendleton, Y. Zeng, Y. Lu, Q. Zhang, Y. Du, B. R. Gilbert, et al. (2013)
Cancer Discovery 3, 761-769
   Abstract »    Full Text »    PDF »
Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers.
C. R. Pickering, J. Zhang, S. Y. Yoo, L. Bengtsson, S. Moorthy, D. M. Neskey, M. Zhao, M. V. Ortega Alves, K. Chang, J. Drummond, et al. (2013)
Cancer Discovery 3, 770-781
   Abstract »    Full Text »    PDF »
Expanding the Foundation for Personalized Medicine: Implications and Challenges for Dentistry.
I. Garcia, R. Kuska, and M. J. Somerman (2013)
Journal of Dental Research 92, S3-S10
   Abstract »    Full Text »    PDF »
Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-{beta}.
Y. Hassona, N. Cirillo, K. P. Lim, A. Herman, M. Mellone, G. J. Thomas, G. N. Pitiyage, E. K. Parkinson, and S. S. Prime (2013)
Carcinogenesis 34, 1286-1295
   Abstract »    Full Text »    PDF »
Notch3 Functions as a Tumor Suppressor by Controlling Cellular Senescence.
H. Cui, Y. Kong, M. Xu, and H. Zhang (2013)
Cancer Res. 73, 3451-3459
   Abstract »    Full Text »    PDF »
Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges.
R. Dienstmann, J. Rodon, J. Barretina, and J. Tabernero (2013)
J. Clin. Oncol. 31, 1874-1884
   Abstract »    Full Text »    PDF »
Genomics-Driven Oncology: Framework for an Emerging Paradigm.
L. A. Garraway (2013)
J. Clin. Oncol. 31, 1806-1814
   Abstract »    Full Text »    PDF »
Clinical Correlates of Promoter Hypermethylation of Four Target Genes in Head and Neck Cancer: A Cooperative Group Correlative Study.
J.-L. Roh, X. V. Wang, J. Manola, D. Sidransky, A. A. Forastiere, and W. M. Koch (2013)
Clin. Cancer Res. 19, 2528-2540
   Abstract »    Full Text »    PDF »
Head and Neck Squamous Cell Carcinoma Sequenced.
Kenneth Y. Tsai, MD, PhD and Kenneth Y. Tsai, MD, PhD (2013)
Journal Watch 2011, JD201109230000003
   Full Text »
Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia.
B. Diaz, A. Yuen, S. Iizuka, S. Higashiyama, and S. A. Courtneidge (2013)
J. Cell Biol. 201, 279-292
   Abstract »    Full Text »    PDF »
Epidermal Growth Factor Receptor Targeting in Head and Neck Cancer: Have We Been Just Skimming the Surface?.
A. R. Hansen and L. L. Siu (2013)
J. Clin. Oncol. 31, 1381-1383
   Full Text »    PDF »
Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling.
J. L. Esseltine, M. D. Willard, I. H. Wulur, M. E. Lajiness, T. D. Barber, and S. S. G. Ferguson (2013)
Mol. Pharmacol. 83, 770-780
   Abstract »    Full Text »    PDF »
A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines.
K. R. Singleton, J. Kim, T. K. Hinz, L. A. Marek, M. Casas-Selves, C. Hatheway, A. C. Tan, J. DeGregori, and L. E. Heasley (2013)
Mol. Pharmacol. 83, 882-893
   Abstract »    Full Text »    PDF »
Cancer Genome Landscapes.
B. Vogelstein, N. Papadopoulos, V. E. Velculescu, S. Zhou, L. A. Diaz Jr., and K. W. Kinzler (2013)
Science 339, 1546-1558
   Abstract »    Full Text »    PDF »
Inflammation and Hras signaling control epithelial-mesenchymal transition during skin tumor progression.
C. E. Wong, J. S. Yu, D. A. Quigley, M. D. To, K.-Y. Jen, P. Y. Huang, R. Del Rosario, and A. Balmain (2013)
Genes & Dev. 27, 670-682
   Abstract »    Full Text »    PDF »
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma.
S. Lyford-Pike, S. Peng, G. D. Young, J. M. Taube, W. H. Westra, B. Akpeng, T. C. Bruno, J. D. Richmon, H. Wang, J. A. Bishop, et al. (2013)
Cancer Res. 73, 1733-1741
   Abstract »    Full Text »    PDF »
Bcl-2 Inhibition or FBXW7 Mutation Sensitizes Solid Tumor Cells to HDAC Inhibition In Vitro but Could Prove Difficult to Validate in Patients.
C. R. Pickering and J. N. Myers (2013)
Cancer Discovery 3, 258-259
   Abstract »    Full Text »    PDF »
Description of the Developmental Patterns of Epithelial Cells and Cancers Originating from Them Will Provide Many Sites for Therapy.
K. M. ANDERSON, P. GUINAN, and M. RUBENSTEIN (2013)
In Vivo 27, 159-163
   Abstract »    Full Text »    PDF »
Competing Roads to Larynx Preservation.
E. E. Vokes (2013)
J. Clin. Oncol. 31, 833-835
   Full Text »    PDF »
Mcl-1 and FBW7 Control a Dominant Survival Pathway Underlying HDAC and Bcl-2 Inhibitor Synergy in Squamous Cell Carcinoma.
L. He, K. Torres-Lockhart, N. Forster, S. Ramakrishnan, P. Greninger, M. J. Garnett, U. McDermott, S. M. Rothenberg, C. H. Benes, and L. W. Ellisen (2013)
Cancer Discovery 3, 324-337
   Abstract »    Full Text »    PDF »
Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies.
D. M. Shin, H. Zhang, N. F. Saba, A. Y. Chen, S. Nannapaneni, A. R. M. R. Amin, S. Muller, M. Lewis, G. Sica, S. Kono, et al. (2013)
Clin. Cancer Res. 19, 1244-1256
   Abstract »    Full Text »    PDF »
Notch pathway activation targets AML-initiating cell homeostasis and differentiation.
C. Lobry, P. Ntziachristos, D. Ndiaye-Lobry, P. Oh, L. Cimmino, N. Zhu, E. Araldi, W. Hu, J. Freund, O. Abdel-Wahab, et al. (2013)
J. Exp. Med. 210, 301-319
   Abstract »    Full Text »    PDF »
Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly.
J. J. Rios, N. Paria, D. K. Burns, B. A. Israel, R. Cornelia, C. A. Wise, and M. Ezaki (2013)
Hum. Mol. Genet. 22, 444-451
   Abstract »    Full Text »    PDF »
Deep Sequencing in Cancer Research.
K. Yoshida, M. Sanada, and S. Ogawa (2013)
Jpn. J. Clin. Oncol. 43, 110-115
   Abstract »    Full Text »    PDF »
Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability.
Y. Drier, M. S. Lawrence, S. L. Carter, C. Stewart, S. B. Gabriel, E. S. Lander, M. Meyerson, R. Beroukhim, and G. Getz (2013)
Genome Res. 23, 228-235
   Abstract »    Full Text »    PDF »
Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.
H. Watanabe, J. M. Francis, M. S. Woo, B. Etemad, W. Lin, D. F. Fries, S. Peng, E. L. Snyder, P. R. Tata, F. Izzo, et al. (2013)
Genes & Dev. 27, 197-210
   Abstract »    Full Text »    PDF »
Dysregulation of the Repressive H3K27 Trimethylation Mark in Head and Neck Squamous Cell Carcinoma Contributes to Dysregulated Squamous Differentiation.
O. M. Gannon, L. Merida de Long, L. Endo-Munoz, M. Hazar-Rethinam, and N. A. Saunders (2013)
Clin. Cancer Res. 19, 428-441
   Abstract »    Full Text »    PDF »
c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met.
L. P. Stabile, G. He, V. W. Y. Lui, S. M. Thomas, C. Henry, C. T. Gubish, S. Joyce, K. M. Quesnelle, J. M. Siegfried, and J. R. Grandis (2013)
Clin. Cancer Res. 19, 380-392
   Abstract »    Full Text »    PDF »
Reflections on the Founding of the International Cancer Genome Consortium.
J. Jennings and T. J. Hudson (2013)
Clin. Chem. 59, 18-21
   Full Text »    PDF »
SCF-Mediated Degradation of p100 (NF-{kappa}B2): Mechanisms and Relevance in Multiple Myeloma.
L. Busino, S. E. Millman, and M. Pagano (2012)
Science Signaling 5, pt14
   Abstract »    Full Text »    PDF »
A Single-Nucleotide Substitution Mutator Phenotype Revealed by Exome Sequencing of Human Colon Adenomas.
S. I. Nikolaev, S. K. Sotiriou, I. S. Pateras, F. Santoni, S. Sougioultzis, H. Edgren, H. Almusa, D. Robyr, M. Guipponi, J. Saarela, et al. (2012)
Cancer Res. 72, 6279-6289
   Abstract »    Full Text »    PDF »
A Mutation in EGF Repeat-8 of Notch Discriminates Between Serrate/Jagged and Delta Family Ligands.
S. Yamamoto, W.-L. Charng, N. A. Rana, S. Kakuda, M. Jaiswal, V. Bayat, B. Xiong, K. Zhang, H. Sandoval, G. David, et al. (2012)
Science 338, 1229-1232
   Abstract »    Full Text »    PDF »
Efficient methods for identifying mutated driver pathways in cancer.
J. Zhao, S. Zhang, L.-Y. Wu, and X.-S. Zhang (2012)
Bioinformatics 28, 2940-2947
   Abstract »    Full Text »    PDF »
Genome Sequencing Identifies a Basis for Everolimus Sensitivity.
G. Iyer, A. J. Hanrahan, M. I. Milowsky, H. Al-Ahmadie, S. N. Scott, M. Janakiraman, M. Pirun, C. Sander, N. D. Socci, I. Ostrovnaya, et al. (2012)
Science 338, 221
   Abstract »    Full Text »    PDF »
Enterococcus faecalis Enhances Cell Proliferation through Hydrogen Peroxide-Mediated Epidermal Growth Factor Receptor Activation.
K. Boonanantanasarn, A. L. Gill, Y. Yap, V. Jayaprakash, M. A. Sullivan, and S. R. Gill (2012)
Infect. Immun. 80, 3545-3558
   Abstract »    Full Text »    PDF »
Comparative Genomic Analysis of Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
N. Agrawal, Y. Jiao, C. Bettegowda, S. M. Hutfless, Y. Wang, S. David, Y. Cheng, W. S. Twaddell, N. L. Latt, E. J. Shin, et al. (2012)
Cancer Discovery 2, 899-905
   Abstract »    Full Text »    PDF »
Notch Signaling.
R. Kopan (2012)
Cold Spring Harb Perspect Biol 4, a011213
   Full Text »    PDF »
Chemopreventive and Chemotherapeutic Actions of mTOR Inhibitor in Genetically Defined Head and Neck Squamous Cell Carcinoma Mouse Model.
Z.-J. Sun, L. Zhang, B. Hall, Y. Bian, J. S. Gutkind, and A. B. Kulkarni (2012)
Clin. Cancer Res. 18, 5304-5313
   Abstract »    Full Text »    PDF »
Molecular Pathways: Context-Dependent Approaches to Notch Targeting as Cancer Therapy.
A. M. Egloff and J. R. Grandis (2012)
Clin. Cancer Res. 18, 5188-5195
   Abstract »    Full Text »    PDF »
Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma.
M. Pavon, M. Parreno, M. Tellez-Gabriel, F. Sancho, M. Lopez, M. Cespedes, I. Casanova, A. Lopez-Pousa, M. Mangues, M. Quer, et al. (2012)
Carcinogenesis 33, 1707-1716
   Abstract »    Full Text »    PDF »
Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors.
A. G. Dumont, Y. Yang, D. Reynoso, D. Katz, J. C. Trent, and D. P. Hughes (2012)
Carcinogenesis 33, 1674-1683
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882